Project Grant R01DA063269
Award Date
7/1/25
Completion Date
3/31/30
Dollars Obligated
$762K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
This federal Project Grant award, with ID R01DA059503, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,192,612 grant will fund a 5-year research project by The Miriam Hospital, a non-profit healthcare and research institution in Providence, RI, to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives of this multidisciplinary research...
This Project Grant award of $1,322,026.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a community-based, longitudinal study to investigate the growing crisis of injection-related wounds and skin and soft tissue infections (IWSTIs) among people who inject drugs (PWID) in North Carolina. The key products and services to be delivered under this grant include: 1) Observing, examining, and categorizing IWSTIs...
This federal Project Grant award of $2,332,500 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The objective of this 4-year project is to build a "prison learning health system" to improve the quality, efficiency, and reach of HIV, HIV risk, and substance use disorder (SUD) care in Washington state prisons. Key innovations include: 1) establishing quality metrics and a patient advisory board to guide...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $460,432 Project Grant to the Regents of the University of Minnesota to develop and pilot a comprehensive telehealth program at syringe service programs (SSPs) to engage people who inject drugs (PWID) into the HIV care continuum. The key products and services to be delivered include: Conducting formative research to understand determinants of HIV and addiction among...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a research study focused on understanding the impact of the opioid fentanyl on individuals with HIV. The total funding amount is $587,188, with the award period running from July 15, 2025 to March 31, 2030. The key products and services to be delivered under this grant include: A multi-omics approach and complementary in vivo and ex vivo studies to...
The National Institute on Drug Abuse (NIDA) awarded a $3,067,394 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The University of Kentucky Research Foundation. The grant, titled "Engaging People Who Use Drugs in Harm Reduction Service Delivery: An Intravention to Reduce Risk of HIV, HCV, Overdose, and Injection-Related Infections in Rural Appalachia," will test a peer-driven approach to address unmet harm reduction needs in two rural Kentucky...
The National Institute on Drug Abuse (NIDA) awarded a $786,979 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of California, San Diego (UCSD) to implement a two-prong hybrid trial focused on improving identification and treatment of substance use disorder (SUD) among sexual and gender minorities of color (SGMC) in Chicago. The first prong involves implementing routine screening for SUD using the NIDA Quick Screen. The second prong is a social network...
This Project Grant award from the National Institute on Drug Abuse (NIDA), with the official CFDA program title "Drug Use and Addiction Research Programs", is funding the development of an educational intervention to train a diverse workforce in addiction data science. The $136,320 award will support the creation of an immersive, tailored addiction data science skills course that provides hands-on training in areas such as FAIR data principles, computational analytics, and natural...